NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31

NutriBand Inc.

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026

$6.00−0.22 (-3.54%)

Close on Oct 19, 2026

Market cap: $72.94M
P/E (TTM): –
Dividend yield: –

NutriBand Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31
Revenue	2.04	2.14	2.09	2.08	1.42	0.94	0.12	0.25	–	–
Cost of Revenue	1.47	1.40	1.22	1.33	0.92	0.63	0.55	0.29	–	–
Gross Profit	0.57	0.74	0.86	0.75	0.55	0.32	-0.43	-0.04	–	–
Research & Development	1.89	3.12	1.96	0.98	0.41	–	–	–	–	–
Selling, General & Admin	6.99	4.31	3.77	3.92	4.02	2.91	1.79	3.29	0.17	0.15
Operating Expenses	8.88	11	5.73	–	6.62	2.91	2.34	3.58	2.67	–
Total Costs & Expenses	10	12	6.96	6.55	7.53	3.54	2.34	–	2.67	0.15
Operating Income	-8.32	-10	-4.87	-4.48	-6.11	-2.60	-1.97	-3.33	-2.67	-0.15
Interest Expense	0.02	0.02	0.08	0.01	0.12	0.28	0.07	–	–	–
Interest & Investment Income	0.11	0.19	0.02	–	–	–	–	–	–	–
Other Non-Operating Income	0.09	-0.20	-0.61	-0.01	6.62	-0.34	-0.75	–	–	–
Asset Impairment Charges	0	3.60	0	-1.05	-0.98	–	–	–	2.50	–
Pretax Income	-8.23	-10	-5.49	-4.48	-6.18	-2.93	-2.72	-3.33	-2.67	–
Income from Continuing Operations	-1.73	-2.20	1.15	-0.94	1.30	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	-6.18	-2.93	-2.77	-3.33	-2.67	-0.15
Net Income	-8.23	-10	-5.49	-4.48	-6.18	-2.93	-2.72	-3.33	-2.67	-0.15
Net Income to Common	-30	-10	–	-4.48	-6.37	-2.93	–	–	–	–
EPS (Basic)(per share)	-2.58	-0.99	-0.69	-0.53	-0.80	-0.51	-0.50	-0.62	-0.56	-0.04
EPS (Diluted)(per share)	-2.58	-0.99	-0.69	-0.53	-0.80	-0.51	-0.50	-0.62	-0.56	-0.04
Shares Outstanding (Basic, Weighted)(shares)	12	11	7.95	8.46	7.93	5.77	5.42	5.35	4.80	5.30
Shares Outstanding (Diluted, Weighted)(shares)	12	11	7.95	8.46	7.93	5.77	5.42	5.35	4.80	5.30
EBITDA	-8.12	-10.00	-4.58	-4.15	-5.80	-2.44	-1.90	-3.29	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 33.1%
Operating margin: -435.6%
Net margin: -430.4%
Return on equity, FY2026: -125.6%

Financial strength

Current ratio: 4.21
Debt to equity: 0.00
Debt to assets: 0.4%
Cash to current liabilities: 377.2%

Valuation

P/E ratio: –
Price to sales: 45.09
Price to book: 13.69
Dividend yield: –